Nephrogenic systemic fibrosis is a newly described systemic disorder that occurs in patients with renal insufficiency. 1,2 The functional consequences of nephrogenic systemic fibrosis are often ...

Mark A. Perazella, MD Exposure to gadolinium-based contrast agents should be minimized in patients with advanced CKD. Nephrogenic systemic fibrosis (NSF), a systemic fibrosing disorder, was first ...

The fibrosis seems to be triggered by an unknown antigenic stimulus that causes the migration of bone-marrow-derived 'circulating fibrocytes' to the skin and other systemic locations and the ...

Nephrogenic systemic fibrosis (NSF) is a serious, recently recognized complication of renal failure that causes cutaneous and visceral fibrosis. Research has been limited to small case series.

Gadolinium-based Contrast Agents Alone Don't Cause Patients To Develop Nephrogenic Systemic Fibrosis. ScienceDaily . Retrieved April 28, 2025 from www.sciencedaily.com / releases / 2009 / 06 ...

Nephrogenic Systemic Fibrosis (NSF) Treatment Market research Report is an inestimable supply of insightful data for business strategists. This Nephrogenic Systemic Fibrosis (NSF) Treatment Market ...

This page lists all known medications that could potentially lead to 'Nephrogenic systemic fibrosis' as a side effect. It's important to note that mild side effects are quite common with medications.

“Our results indicate that the risk of nephrogenic systemic fibrosis when using group II gadolinium-based contrast agents—gadobenate dimeglumine, gadobutrol, gadoterate meglumine, or ...

Patients with chronic kidney disease (CKD) who receive a gadolinium-based contrast agent (GBCA) have a low risk of developing nephrogenic systemic fibrosis (NSF), a systematic review and meta ...

These contrast agents have been linked to nephrogenic systemic fibrosis (NSF) and nephrogenic fibrosing dermopathy (NFD). These potentially fatal diseases cause thickening of the skin and ...

Nephrogenic systemic fibrosis (NSF) is a newly described, uncommon disease typically affecting middle-aged patients suffering from end-stage renal disease. The underlying etiology of this serious ...

Nephrogenic diabetes insipidus is a long name for an uncommon condition. Nephrogenic diabetes insipidus is not the same as diabetes mellitus. Diabetes mellitus causes elevated blood sugar levels ...